Webcast

The Journey Toward Paperless Clinical Trials


To view the media player you will need Adobe Flash!
Download Adobe Flash
The video player is loading...
Pharma companies are seeking to bolster pipelines and cut costs more than ever before in preparation for looming patent expirations of blockbuster drugs. In this environment global collaborations are increasing while budgets are shrinking, and as a result Internet-based communication has taken a prominent position in clinical development.

In contrast to the rapid changes in the structure of development teams and the advancements in web-based communications tools, the progress toward completely paperless clinical trials has been notably slow.  Are we about to turn the corner and see new momentum? In over two decades since the first remote data entry systems were introduced, interfaces and speed of computer-based systems have improved greatly, yet the challenges of managing the paper distribution, collection and management of clinical regulatory documents in clinical trials persists.

Discussion includes:
  • The push for paperless continues: A look at the latest trends and initiatives
  • Clinical studies end-to-end: Which parts of the process are farthest along and which have the highest hurdles
  • Who benefits? Views on the benefits and burdens of transitioning to paperless for sites, sponsors, regulators and others
  • Where from here? Practical next steps towards the paperless trial

More Webcasts

Live Webcast Replay: An Outlook on Global M&A Activity

As dealmakers across the world re-enter the M&A marketplace, there is regional disparity. Professionals in Europe and the US, though more confident, have yet to see a large increase in dealmaking, whereas Asia-Pacific practitioners are riding high on the crest of a new wave of activity. With such differences, it is important for those involved in M&A to understand the global picture in order to identify and maximize opportunities.

In advance of the release of the latest IntraLinks survey entitled "Global M&A Survey - An Outlook on Global M&A Activity and Future Deal Flow", mergermarket and IntraLinks are hosting this complimentary webcast featuring expert speakers who will examine the report's key findings and discuss the latest trends in the global M&A landscape.

PLAY WEBCAST


Live Panel Discussion Replay: The Globalization of Clinical Trials - The Good, The Bad & The Overall Impact on Pharma Development

The last decade has seen the proliferation of multinational clinical trials having sites in six or more countries, often spanning two or even three continents. The expansion of clinical trials to previously untapped locations has had many benefits:

  • Improved ability to maintain strong recruitment rates
  • Advanced capability to file/launch a new drug in many markets quickly


PLAY WEBCAST


Live Webcast Replay: Better Execution, Earlier: Accelerating Deal Preparation and Pre-Due Diligence

Learn how leveraging the IntraLinks Deal Team Exchange can make the deal process faster, more efficient, and less cumbersome. In this interactive webcast, our sales engineer walks you through how using a Deal Team Exchange can get the team up and running to keep the process on track. This includes a deep dive in the key functionality for accelerating deal preparation and pre-due diligence.

PLAY WEBCAST


Interview: Thomas Sabatino at the Argyle Chief Legal Officer Forum

Tom Sabatino delivered a keynote speech on the need for tighter integration between corporate legal teams and their law firms. In our interview with Tom, he further emphasized that collaboration is the foundation for effective management of legal departments, and that technology like IntraLinks can significantly enhance this process. See Tom's insight here.

PLAY WEBCAST


Podcast: Inside The Records Room with Bob Little from AIIM's Info360 Conference

Bob Little, Vice President of Product Marketing at IntraLinks is interviewed by Ray Davis and Jeff Glover from Inside The Records Room at AIIM's Info360 Conference in Philadelphia, Pennsylvania. Bob and Ray discuss issues related to content and collaboration.

PLAY PODCAST